Mayne outlook rosy despite effect of tariffs on big pharma
Mayne Pharma, which is the target of a $672m foreign takeover bid, appears unperturbed by the likely impact of Donald Trump’s import tariffs on the drug sector.
Mayne Pharma, which is the target of a $672m foreign takeover bid, appears unperturbed by the likely impact of Donald Trump’s import tariffs on the drug sector.
Billionaire Andrew Forrest is not giving up entirely on his hydrogen dreams, backing Perth-based HyTerra in a US-drilling program.
Dairy group Fonterra has named a new audit chair as it prepares for the sale of its consumer business in Australia and New Zealand.
Star Entertainment’s US-based white knight Bally’s Corp is facing its own financial headaches at home but claims it has the strength to close the Australian deal.
Star Entertainment’s losses have deepened, underscoring the challenges its new US owners face in turning the troubled business around.
Bally’s boss Soo Kim is exploring options to remain involved in Star’s prized Queen’s Wharf casino precinct as either owner or operator.
The casino boss set to take control of Star Entertainment is working on a ‘day one action plan’ to fundamentally change the way the cash-strapped resort operates.
US-based casino giant Bally’s says its buyout will allow Star Entertainment to regain its position as ‘Australia’s preeminent gaming destination’.
Troubled casino operator Star Entertainment has accepted a $300m takeover offer from US-based Bally’s Corp, helping it narrowly avoid administration.
Crown claims it now runs one of the safest casinos in the world in terms of customer welfare, with its dedicated team on the lookout for early warning signs of problem gambling.
Original URL: https://www.couriermail.com.au/journalists/glen-norris/page/2